0001178913-23-000076.txt : 20230105 0001178913-23-000076.hdr.sgml : 20230105 20230105160117 ACCESSION NUMBER: 0001178913-23-000076 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mor George Adi CENTRAL INDEX KEY: 0001851069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38807 FILM NUMBER: 23511204 MAIL ADDRESS: STREET 1: 15 KAFRISIN ST. CITY: TEL AVIV STATE: L3 ZIP: 6901658 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd. CENTRAL INDEX KEY: 0001534248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813676773 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV STATE: L3 ZIP: 6158002 BUSINESS PHONE: 972-77-331-0156 MAIL ADDRESS: STREET 1: KIRYAT ATIDIM, BUILDING 7 CITY: TEL AVIV STATE: L3 ZIP: 6158002 FORMER COMPANY: FORMER CONFORMED NAME: Anchiano Therapeutics Ltd. DATE OF NAME CHANGE: 20180906 FORMER COMPANY: FORMER CONFORMED NAME: BioCancell Ltd. DATE OF NAME CHANGE: 20111104 4 1 ownership.xml X0306 4 2023-01-03 0 0001534248 Chemomab Therapeutics Ltd. CMMB 0001851069 Mor George Adi 15 KAFRISIN ST. TEL AVIV L3 6901658 ISRAEL 1 1 0 0 Chief Scientific Officer American Depositary Shares 2023-01-03 4 S 0 7700 5.0268 D 317075 D American Depositary Shares 2023-01-03 4 S 0 6100 5.0268 D 251147 I By Kobi George, the Reporting Person's spouse Option to Purchase American Depositary Shares 1.49 2018-03-15 4 A 0 131698 0 A 2028-03-15 American Depositary Shares 131698 131698 D Option to Purchase American Depositary Shares 0.8 2016-10-28 4 A 0 33725 0 A 2026-10-27 American Depositary Shares 33725 33725 I By Kobi George, the Reporting Person's spouse Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer. This transaction was effected pursuant to a 10b5-1 plan entered into on September 19, 2022. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. These options have vested and are exercisable as of the date hereof. These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service. /s/ David S. Glatt, Attorney-in-Fact for Adi Mor and Kobi George. 2023-01-05